PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 42 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

20 April 2025

  1. (diff | hist) 22:14 Mass spectrometry 5,248 +25 TFA_Counterion (talk | contribs) typo [rollback]
  2. (diff | hist) 20:42 Bacterial endotoxin test 4,398 ±0 Chromatokid (talk | contribs) add the sample preparation, since the result depends on it [rollback]
  3. (diff | hist) 17:01 Patent expiry and biosimilars 3,580 +369 BiosimilarBoaz (talk | contribs) attribute the compounding statement to the pharmacy board that issued it [rollback]
  4. (diff | hist) 13:25 Incretin effect 5,768 ±0 DMF_Dermot (talk | contribs) de-orphan [rollback]
  5. (diff | hist) 08:46 Cost per milligram 3,122 +121 Chromatokid (talk | contribs) add the note that prices below the list price are not evidence of a counterfeit [rollback]
  6. (diff | hist) 07:28 Good manufacturing practice 3,919 ±0 GMP_Gita (talk | contribs) add the good-manufacturing-practice framework by name [rollback]
  7. (diff | hist) m 06:41 International nonproprietary name 3,183 +38 DulaglutideDug (talk | contribs) rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]

19 April 2025

  1. (diff | hist) 20:19 ChinaPeptides 7,910 +549 MicrodoseMagnus (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  2. (diff | hist) 16:19 Tianjin Finder Chemical 7,627 +771 VerifyFirstVida (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  3. (diff | hist) 13:12 Melanotan II 3,650 ±0 IpamorelinIsold (talk | contribs) expand §Pharmacology [rollback]
  4. (diff | hist) 12:19 Amylin 4,252 ±0 LipidLedgerLou (talk | contribs) expand §Amyloid formation [rollback]
  5. (diff | hist) 10:53 Grey market 3,184 +579 ForestPlotFinn (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]
  6. (diff | hist) m b 09:06 Sterility testing 3,636 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]

18 April 2025

  1. (diff | hist) 23:54 SURPASS trial programme 4,474 +516 AppendixAlva (talk | contribs) expand §The head-to-head comparison [rollback]
  2. (diff | hist) m 23:16 Temperature excursion 3,988 +749 CouplingCillian (talk | contribs) split overlong sentence [rollback]
  3. (diff | hist) m 21:31 Liquid chromatography-mass spectrometry 3,724 ±0 KarlFischerKit (talk | contribs) clarify that area percent is not mass percent [rollback]
  4. (diff | hist) m 19:54 Lot traceability 4,002 ±0 MolarMassMaeve (talk | contribs) clarify that a certificate is a claim by its issuer [rollback]
  5. (diff | hist) 19:17 Reconstitution of lyophilised peptides 5,243 +854 GramsNotUnitsGil (talk | contribs) serial comma per PP:MOS [rollback]
  6. (diff | hist) m 11:10 Insulin syringe 4,667 +556 BacWaterBarnaby (talk | contribs) the rounding in the table lost a decimal place that matters at low doses [rollback]
  7. (diff | hist) 09:01 HOMA-IR 3,431 ±0 GMP_Gita (talk | contribs) rm the claim that the marker predicts outcome; the cited study is cross-sectional [rollback]
  8. (diff | hist) 05:09 Missed dose 4,407 ±0 GMP_Gita (talk | contribs) serial comma per PP:MOS [rollback]
  9. (diff | hist) 03:23 Amino acid analysis 4,038 +335 DiluentDiya (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  10. (diff | hist) m b 00:18 Triple agonist 3,428 ±0 CiteBot (talk | contribs) bot: expand DOI to full citation [rollback]

17 April 2025

  1. (diff | hist) 15:35 Glucagon-like peptide-1 10,252 +13 StopperingSteff (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]
  2. (diff | hist) 15:17 Drug master file 3,312 +132 StateBoardStace (talk | contribs) name the regulator rather than writing "the authorities" [rollback]
  3. (diff | hist) m b 14:58 Baseline laboratory panel 3,526 +487 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  4. (diff | hist) m 12:04 Shanghai Sigma-Audley New Material Technology 8,287 +770 BatchNumberBede (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  5. (diff | hist) 09:42 Beta cell function 4,916 ±0 DefinedTermDov (talk | contribs) add the counter-regulatory glucagon point, sourced [rollback]
  6. (diff | hist) m 07:41 USP General Chapter 71 3,363 ±0 SchematicScout (talk | contribs) add the repeatability figure with the number of injections [rollback]
  7. (diff | hist) m 04:21 GL Biochem (Shanghai) 13,765 +810 PurityClaimPia (talk | contribs) clarify that no manufacturing or marketing authorisation is claimed or established [rollback]
  8. (diff | hist) 02:11 Personal importation policy 3,251 +96 LabelLibby (talk | contribs) add category for drug regulation [rollback]

16 April 2025

  1. (diff | hist) m 22:03 Satiety signalling 4,441 ±0 SatietySunniva (talk | contribs) split overlong sentence [rollback]
  2. (diff | hist) 19:26 Glucose-dependent insulinotropic polypeptide 6,711 +25 ReceptorRhoda (talk | contribs) clarify that the incretin effect is defined by the oral–intravenous comparison [rollback]
  3. (diff | hist) N 09:00 Temperature excursion 3,239 +3,239 SyringeSybille (talk | contribs) create article — process stub
  4. (diff | hist) 08:32 Vial 19,236 +957 DrTitration (talk | contribs) expand §Sealing and capping [rollback]
  5. (diff | hist) m b 07:57 Chain of custody 4,085 ±0 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 07:41 MOTS-c 3,310 +62 GHK_Gwendolen (talk | contribs) space between number and unit per PP:MOS [rollback]
  7. (diff | hist) 06:52 ISO 9001 3,340 ±0 TrialsTabitha (talk | contribs) typo [rollback]

15 April 2025

  1. (diff | hist) 19:35 Janoshik Analytical 4,969 +843 LeanMassLars (talk | contribs) add the difference between a batch certificate and a lot-specific one [rollback]
  2. (diff | hist) m 09:13 Resin cleavage 3,277 ±0 SPPS_Sorrel (talk | contribs) give the closure integrity test by name [rollback]
  3. (diff | hist) 09:03 Beyond-use date 13,131 +17 UnitAuditUwe (talk | contribs) correct the needle gauge given for subcutaneous administration [rollback]
  4. (diff | hist) 09:03 Talk:Blind sampling 959 +122 NPOV_Nadia (talk | contribs) /* Selection on the outcome is a third failure, not a footnote */ reply
  5. (diff | hist) 03:03 Research use only 6,689 ±0 API_Aurora (talk | contribs) expand §What the category excludes [rollback]

14 April 2025

  1. (diff | hist) m b 21:58 Tirzepatide 6,572 +243 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]
  2. (diff | hist) 17:50 Orforglipron 4,465 +300 TimelineTiernan (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  3. (diff | hist) 15:12 Talk:Blind sampling 748 +155 ReportReaderRilla (talk | contribs) /* Selection on the outcome is a third failure, not a footnote */ reply
  4. (diff | hist) 13:11 Chinese Peptide Company 10,821 +321 IsocraticIla (talk | contribs) rm the adjective — an organisation article describes, it does not praise [rollback]
  5. (diff | hist) m b 12:02 Trifluoroacetate counterion 3,899 ±0 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  6. (diff | hist) 11:50 Talk:Wuhan Wansheng Biotechnology 1,666 +396 RfC_Rasmus (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  7. (diff | hist) 10:38 Talk:Blind sampling 537 +216 TallySheetTad (talk | contribs) /* Selection on the outcome is a third failure, not a footnote */ new section
  8. (diff | hist) 01:13 Limit of detection 3,971 ±0 MelanocortinMil (talk | contribs) expand §Practical consequences [rollback]

13 April 2025

  1. (diff | hist) m 23:14 Customs seizure 3,644 +497 LabelLibby (talk | contribs) fix the anchor on an internal link [rollback]
  2. (diff | hist) m 22:40 Sarcopenia 3,440 ±0 A1c_Alder (talk | contribs) expand §Relevance to weight reduction [rollback]
  3. (diff | hist) 20:03 Peptide aggregation 4,377 ±0 PeakShapePol (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  4. (diff | hist) m 12:23 WuXi TIDES 10,659 +479 EndotoxinEd (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  5. (diff | hist) m 07:05 Fmoc chemistry 4,430 +18 FreightFenna (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  6. (diff | hist) m b 06:24 Dulaglutide 4,161 ±0 StubSorterBot (talk | contribs) bot: expand DOI to full citation [rollback]
  7. (diff | hist) 04:00 Peptide 4,971 +38 SupplyWatchSuri (talk | contribs) expand §Nomenclature and notation [rollback]
  8. (diff | hist) 02:18 C-peptide 3,458 ±0 DEXA_Dilys (talk | contribs) add the interference the assay is known to be subject to [rollback]
  9. (diff | hist) 02:15 Underfilling 3,432 +34 SurvodutideSaff (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]

12 April 2025

  1. (diff | hist) m b 23:01 Growth hormone secretagogue 3,620 +44 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) 22:48 Loss on drying 3,735 ±0 SVG_Solomon (talk | contribs) add the plate-count expression and define its terms [rollback]
  3. (diff | hist) 22:32 Adverse effects of GLP-1 receptor agonists 5,297 ±0 SchemaSorcha (talk | contribs) alphabetise the see-also list [rollback]
  4. (diff | hist) 16:56 Deamidation 4,219 ±0 TrialsTabitha (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]
  5. (diff | hist) m 15:36 USP General Chapter 85 4,270 ±0 ColumnOvenCoy (talk | contribs) fix a broken wikilink [rollback]
  6. (diff | hist) 15:34 Exenatide 4,449 +161 OrforglipronOona (talk | contribs) expand §The extended-release formulation [rollback]
  7. (diff | hist) 09:49 Flourishglobal Peptide Biotech 5,361 +686 BUD_Bertram (talk | contribs) move a stray full stop inside the reference [rollback]
  8. (diff | hist) 07:38 Contract development and manufacturing organisation 3,804 ±0 StopperingSteff (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]
  9. (diff | hist) m 04:47 List of GLP-1 receptor agonists 3,023 ±0 PriorAuthPaz (talk | contribs) split the list at the point where the subject changes [rollback]
  10. (diff | hist) 01:37 Xi'an Mokemei Biotechnology 3,064 +696 KarlFischerKit (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  11. (diff | hist) 00:16 FLOW trial 3,481 +25 EndpointEnid (talk | contribs) give the absolute risk difference alongside the relative one [rollback]

11 April 2025

  1. (diff | hist) 23:18 Prior authorisation 3,094 ±0 TitrationTheo (talk | contribs) de-duplicate a repeated sentence [rollback]
  2. (diff | hist) 22:08 Regulatory status by jurisdiction 3,391 ±0 FiveOhThreeB (talk | contribs) state that the position differs between jurisdictions and give two examples [rollback]
  3. (diff | hist) m 19:42 TRIUMPH trial programme 4,014 ±0 DrTitration (talk | contribs) the percentage quoted was placebo-adjusted; label it [rollback]
  4. (diff | hist) 10:40 Hubei Jianxiang Bioscience 2,167 +450 BlankVialBo (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  5. (diff | hist) 10:05 Blind sampling 6,780 ±0 SecondarySrc_Seb (talk | contribs) add category for certificates of analysis [rollback]
  6. (diff | hist) 09:33 Talk:Wuhan Wansheng Biotechnology 1,455 +402 VerifyFirstVida (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  7. (diff | hist) m b 03:34 Semaglutide 8,079 ±0 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]
  8. (diff | hist) m 03:31 Sterile water for injection 3,619 ±0 AnalyticalAnnie (talk | contribs) add the dead-space volume to the worked example [rollback]

10 April 2025

  1. (diff | hist) m 19:09 Cold-chain freight 3,699 ±0 RedirectRini (talk | contribs) expand §How much it matters for a lyophilised peptide [rollback]
  2. (diff | hist) 18:11 Subcutaneous injection 4,039 ±0 SortKeySascha (talk | contribs) correct the needle gauge given for subcutaneous administration [rollback]
  3. (diff | hist) 17:34 GLP-1 receptor agonist 9,254 ±0 AxisLabelAgda (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  4. (diff | hist) 17:24 Injection site rotation 4,064 +167 EscalationEira (talk | contribs) state that swirling rather than shaking is the handling convention, sourced [rollback]
  5. (diff | hist) 10:04 Talk:Wuhan Wansheng Biotechnology 1,244 +217 PuffRemoverPax (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  6. (diff | hist) 09:14 Talk:Cold chain 1,170 +94 PlainNumbersPip (talk | contribs) /* Mean kinetic temperature: the worked example */ reply
  7. (diff | hist) m 08:30 Body composition assessment 4,384 +220 PanelPlannerPam (talk | contribs) convert a hard-coded date to the house format [rollback]
  8. (diff | hist) 04:13 Peptide supply chain 6,954 +894 Hedgerow_Hal (talk | contribs) give the closure integrity test by name [rollback]

9 April 2025

  1. (diff | hist) m 23:54 Shanghai Wibson Biotechnology 6,377 +722 LotTraceLuka (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  2. (diff | hist) 22:31 Hunan Aslsen Technology 8,998 +519 SecondarySrc_Seb (talk | contribs) expand §Reception [rollback]
  3. (diff | hist) 21:55 Residual solvent 4,125 ±0 SigFigSindri (talk | contribs) move a stray full stop inside the reference [rollback]
  4. (diff | hist) 20:23 Glucagon 5,754 ±0 BPC_Bramwell (talk | contribs) sentence case in headings per PP:MOS [rollback]
  5. (diff | hist) 20:22 CagriSema 4,167 +280 ImageReuseIris (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  6. (diff | hist) 16:15 VendorInvestigate 4,188 ±0 AnalyticalAnnie (talk | contribs) add the note that a purity figure without water and counterion is not a mass [rollback]
  7. (diff | hist) 15:47 Purity claim inflation 4,595 ±0 BlindSampleBrid (talk | contribs) state the date range the submitted set covers [rollback]
  8. (diff | hist) m 14:30 PeptideMeter 3,873 ±0 TallySheetTad (talk | contribs) add the difference between a batch certificate and a lot-specific one [rollback]
  9. (diff | hist) 14:01 Cagrilintide 3,187 ±0 CuriousCallum (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  10. (diff | hist) 11:27 Talk:Wuhan Wansheng Biotechnology 1,033 +261 NPOV_Nadia (talk | contribs) /* RfC: what does a large report set actually support? */ reply
  11. (diff | hist) 10:29 Certificate of analysis 7,513 +541 PancreasPru (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  12. (diff | hist) m 09:08 Sangon Biotech 6,905 +144 UnderfillUna (talk | contribs) expand §Notability and coverage [rollback]
  13. (diff | hist) 08:55 Talk:Cold chain 959 +284 SigFigSindri (talk | contribs) /* Mean kinetic temperature: the worked example */ reply